CIMG Direct Offering up to 900M Units; Secondary 43M Shares
CIMG Inc. filed an S-1/A for a direct offering of up to 900,000,000 units (common stock and warrants) to non-U.S. investors, with an initial closing for approximately $13.5 million in Bitcoin and potential total gross proceeds of up to $650 million. Concurrently, certain stockholders are offering up to 43,000,000 shares in a secondary offering. The company was delisted from Nasdaq in March 2026 and is appealing the decision, with its common stock now quoted on OTC Markets. CIMG has undergone a business transformation, expanding into health and wellness products (Maca, traditional Chinese medicine series) and AI computing power products, while also adopting Bitcoin as a long-term reserve asset. The filing highlights significant legal and operational risks associated with its operations in China and Hong Kong, including regulatory uncertainties and potential impacts from PRC government policies.
Key Highlights
- Direct offering of up to 900,000,000 units (common stock + warrants).
- Initial closing of direct offering for approx. $13,500,000 in Bitcoin.
- Potential total gross proceeds from direct offering up to $650,000,000.
- Secondary offering of up to 43,000,000 common shares by selling stockholders.
- Delisted from Nasdaq on March 4, 2026; appealing decision.
- Expanded business into Maca-enhanced foods, health & wellness, and AI computing.
- Adopted Bitcoin as a long-term reserve asset; first purchase Oct 20, 2025.
- Operations in China/Hong Kong face significant regulatory and operational risks.
Price Impact
More from CIMG